Pop Health 4.0: Where population health is heading

With predictive risk scores and care management data, providers can proactively target "high and rising risk populations" and treat behavioral health with urgency, says Yagnesh Vadgama, VP of payor strategy and network development at CentralReach.

Matthew Laskowski, CEO of Toby, discusses the machine learning and biomarker analysis technology behind the company’s urine-based multi-cancer detection test that has received FDA Breakthrough Device designation in the United States.

The challenge is having that information flow be more proactive, says Dr. Steven Lane, CMO of Health Gorilla.